Share:

Tumor Immunotherapy Efficacy Increased In Both Breast And Prostate Cancer …
Daily Markets
NORCROSS, Ga., June 12, 2013 /PRNewswire-USNewswire/ — Galectin Therapeutics (GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that preclinical studies have shown that … The …

http://www.dailymarkets.com/stock/2013/06/12/tumor-immunotherapy-efficacy-increased-in-both-breast-and-prostate-cancer-preclinical-models-with-addition-of-galectin-inhibitor/

Tweet